Stage
No active trials
Next date
None yet
Trials
0 active
1 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- Tested for
- Ureter Injury
- Main trialPhase 2
- “This study evaluates the safety and efficacy of intravenous injection of IS-001 to aid in intraoperative ureter structure delineation. Stage A of the study will determine the safe optimal dose and Stage B will determine expanded safety and efficacy for intraoperative ureter structure delineation for the identified optimal dose in study participants.”In the company’s words, NCT03937505 on ClinicalTrials.gov
Other drugs for Ureter Injury
- LY4101174Eli Lilly · Phase 1
- LY4052031Eli Lilly · Phase 1
- VepugratinibEli Lilly · Phase 1
Coming up0
No dates coming up.
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials1
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 2Completed | 8 Jul 2021 | A Safety and Efficacy Study of IS-001 Injection in Patients Undergoing Robotic Hysterectomy |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026